THE Therapeutic Goods Administration (TGA) has issued two infringement notices totalling $26,640 to a Perth-based company G1 Resources Pty Ltd, for the alleged unlawful importation and advertising of COVID-19 rapid antigen tests (RATs).
"G1 Resources Pty Ltd allegedly imported 600 RATs that were not on the Australian Register of Therapeutic Goods (ARTG) at the time of importation," the TGA said.
"The RATs were a parallel import of a similar Australian approved product.
"RATs imported for commercial supply must be the version manufactured and approved for the Australian market.
"The RATs must be included in the ARTG under the name of the sponsor, prior to importation."
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Apr 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Apr 22
